The Power of Modern Medicine

Week in Review: The Significance of Forward-Looking Progress

12.13.13 | By

Discovering and developing new treatments for the world’s most pressing health challenges helps inspire the work of innovators across the biopharmaceutical sector. More importantly, it’s our end-goal to ensure that patients around the world can obtain such innovative treatments in a timely manner. The importance of forward progress in each step of the research and development process cannot be stressed enough, and must be a continued priority for every treatment that comes through the pipeline. 

We were reminded of the power of modern medicine and the advancement of medical innovation as we celebrated the 26th Anniversary of World AIDS Day earlier this month. An HIV/AIDS diagnosis that was once a death sentence has been transformed into a chronic disease. This week, we highlighted this medical progress, as well as the 394 other medicines in development for infectious diseases, which affect more than two million Americans annually.  With the help of vaccines, 10 infectious diseases have been at least 90 percent eradicated in the U.S. We hope to continue to control or eradicate infectious diseases such as Hepatitis C and HIV with effective treatments stemming from research and development, and a constant goal of advancing progress however possible.

In our “Conversations” forum, we focused on medical advancements to help treat Neglected Tropical Diseases (NTDs), asking experts what is being done to get treatments to the more than 1 billion people who are affected by NTDs. With the help of medical innovation, public and private partnerships and the dedication of many volunteers, treatments are being distributed to patients in need worldwide. As we had many diverse responses and unique insights into treating NTDs, we encourage you to take some time and read what these knowledgeable contributors had to say.   

As always, we welcome your thoughts and input on topics that impact patients across the globe. Be sure to check in with The Catalyst each week to learn more about the progress our member companies are making and the new treatments that will help patients live longer, healthier and more productive lives.

More On PhRMA — powered by PhRMApedia


Cost in Context